Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Immunic, Inc. - Common Stock (NQ:IMUX)

13.81 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 27, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 79
Open 13.81
Bid (Size) 9.040 (100)
Ask (Size) 17.03 (100)
Prev. Close 13.81
Today's Range 13.81 - 13.81
52wk Range 5.062 - 15.84
Shares Outstanding 26,249,439
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Stock Market Today, March 24: Oil, AI, and Private Credit Fears Weigh on Markets ↗
On March 24, 2026, choppy, oil-driven trading and fresh AI disruption fears pressured major U.S. indexes. 
Via The Motley Fool
Topics Artificial Intelligence Economy Stocks
Which stocks have an unusual volume on Tuesday? ↗
Via Chartmill

Performance

YTD
+136.9%
+136.9%
1 Month
-10.4%
-10.4%
3 Month
+38.4%
+38.4%
6 Month
+99.5%
+99.5%
1 Year
+27.9%
+27.9%

More News

Read More
News headline image
Immunic Stock Jumps After Pricing $400 Million Private Placement ↗
Via Benzinga
Traders are paying attention to the gapping stocks in Friday's session. ↗
Via Chartmill
What's going on in today's pre-market session ↗
Via Chartmill
News headline image
Why Did IMUX Stock Surge 33% Pre-Market Today? ↗
Via Stocktwits
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
Via Benzinga
News headline image
This Electronic Arts Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday ↗
Via Benzinga
News headline image
This VSE Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday ↗
Via Benzinga
News headline image
Immunic (IMUX) Q2 Loss Widens 25% ↗
Via The Motley Fool
News headline image
Immunic Announces Vidofludimus Calcium Reduced Risk of Disability Worsening by 30% in Primary Progressive Multiple Sclerosis Patients from Phase 2 CALLIPER Trial ↗
Via Stocktwits
News headline image
Immunic to Participate in Scientific and Industry Conferences in May ↗
Via Stocktwits
Topics Economy
News headline image
Immunic, Inc. Announces Proposed Public Offering ↗
Via Stocktwits
Topics Regulatory Compliance
News headline image
Immunic, Inc. Announces Pricing of Oversubscribed $65 Million Underwritten Public Offering ↗
Via Stocktwits
News headline image
Immunic to Participate in Investor, Scientific and Industry Conferences in June ↗
Via Stocktwits
Topics Intellectual Property
News headline image
Immunic, Inc. Announces Closing of Oversubscribed $65 Million Underwritten Public Offering ↗
Via Stocktwits
News headline image
Immunic Announces Completion of Enrollment for Both Phase 3 ENSURE Trials in Relapsing MS and Presents Additional Data Underlining Positive Outcome of Phase 2 CALLIPER Trial in Progressive MS ↗
Via Stocktwits
News headline image
Immunic Reports New, Positive Long-Term Open-Label Extension Data From Phase 2 EMPhASIS Trial of Vidofludimus Calcium in Relapsing-Remitting Multiple Sclerosis ↗
Via Stocktwits
News headline image
Let's take a look at the stocks that are in motion in today's session. ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
Via Benzinga
News headline image
Wednesday's session: top gainers and losers ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
Via Benzinga
News headline image
Wednesday's session: gap up and gap down stocks ↗
Via Chartmill
News headline image
These stocks that are showing activity before the opening bell on Wednesday. ↗
Via Chartmill

Frequently Asked Questions

Is Immunic, Inc. - Common Stock publicly traded?
Yes, Immunic, Inc. - Common Stock is publicly traded.
What exchange does Immunic, Inc. - Common Stock trade on?
Immunic, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Immunic, Inc. - Common Stock?
The ticker symbol for Immunic, Inc. - Common Stock is IMUX on the Nasdaq Stock Market
What is the current price of Immunic, Inc. - Common Stock?
The current price of Immunic, Inc. - Common Stock is 13.81
When was Immunic, Inc. - Common Stock last traded?
The last trade of Immunic, Inc. - Common Stock was at 07/27/26 04:00 PM ET
What is the market capitalization of Immunic, Inc. - Common Stock?
The market capitalization of Immunic, Inc. - Common Stock is 362.50M
How many shares of Immunic, Inc. - Common Stock are outstanding?
Immunic, Inc. - Common Stock has 363M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.